Advertisement
help button home button The Oncologist
HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow eLetters: Submit a response to this article
Right arrow Purchase Article
Right arrow View Shopping Cart
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow E-mail this article link to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Reprints/Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Rose, M. G.
Right arrow Articles by Berliner, N.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Rose, M. G.
Right arrow Articles by Berliner, N.
The Oncologist, Vol. 9, No. 3, 247–258, June 2004
© 2004 AlphaMed Press

T-Cell Large Granular Lymphocyte Leukemia and Related Disorders

Michal G. Rosea, Nancy Berlinerb

a Yale University School of Medicine, The Comprehensive Cancer Center (IIID), VA Connecticut Healthcare System, West Haven, Connecticut, USA; b Section of Hematology, Yale University School of Medicine, New Haven, Connecticut, USA

Correspondence: Michal G. Rose, M.D., The Comprehensive Cancer Center (IIID), VA Connecticut Healthcare System, 950 Campbell Avenue, West Haven, Connecticut 06516, USA. Telephone: 203-937-3421; Fax: 203-937-3803; e-mail: Michal.Rose{at}med.va.gov, michalrose{at}sbcglobal.net

T-cell large granular lymphocyte (LGL) leukemia is a clonal proliferation of cytotoxic T cells, which causes neutropenia, anemia, and/or thrombocytopenia. This condition is often associated with autoimmune disorders, especially rheumatoid arthritis, and other lymphoproliferative disorders. The diagnosis is suggested by flow cytometry demonstrating an expansion of CD8+CD57+ T cells and is confirmed by T-cell receptor gene rearrangement studies. Mounting evidence suggests that LGL leukemia is a disorder of dysregulation of apoptosis through abnormalities in the Fas/Fas ligand pathway. In most patients, this is an indolent disorder, and significant improvement of cytopenias can be achieved with immunosuppressive agents such as steroids, methotrexate, cyclophosphamide, and cyclosporin A. This review provides a concise, up-to-date summary of LGL leukemia and the related, more aggressive, malignancies of cytotoxic T cells and natural killer cells.

Key Words. Chronic T-cell leukemia • Felty’s syndrome • Neutropenia • Natural killer cell




This article has been cited by other articles:


Home page
 haematolHome page
S. R. Mohan, M. J. Clemente, M. Afable, H. N. Cazzolli, N. Bejanyan, M. W. Wlodarski, A. E. Lichtin, and J. P. Maciejewski
Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia
Haematologica, October 1, 2009; 94(10): 1407 - 1414.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z.-R. Yuan and Y. Shi
Chloramphenicol Induces Abnormal Differentiation and Inhibits Apoptosis in Activated T Cells
Cancer Res., June 15, 2008; 68(12): 4875 - 4881.
[Abstract] [Full Text] [PDF]

Home page
 Toxicol SciHome page
J. Thomas, J. K. Haseman, J. I. Goodman, J. M. Ward, T. P. Loughran Jr, and P. J. Spencer
A Review of Large Granular Lymphocytic Leukemia in Fischer 344 Rats as an Initial Step Toward Evaluating the Implication of the Endpoint to Human Cancer Risk Assessment
Toxicol. Sci., September 1, 2007; 99(1): 3 - 19.
[Abstract] [Full Text] [PDF]

Home page
 Cancer Res.Home page
Z.-R. Yuan, R. Wang, J. Solomon, X. Luo, H. Sun, L. Zhang, and Y. Shi
Identification and Characterization of Survival-Related Gene, a Novel Cell Survival Gene Controlling Apoptosis and Tumorigenesis
Cancer Res., December 1, 2005; 65(23): 10716 - 10724.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
F. Ravandi and S. O'Brien
Chronic Lymphoid Leukemias Other Than Chronic Lymphocytic Leukemia: Diagnosis and Treatment
Mayo Clin. Proc., December 1, 2005; 80(12): 1660 - 1674.
[Abstract] [PDF]

Home page
 BloodHome page
M. W. Wlodarski, C. O'Keefe, E. C. Howe, A. M. Risitano, A. Rodriguez, I. Warshawsky, T. P. Loughran Jr, and J. P. Maciejewski
Pathologic clonal cytotoxic T-cell responses: nonrandom nature of the T-cell-receptor restriction in large granular lymphocyte leukemia
Blood, October 15, 2005; 106(8): 2769 - 2780.
[Abstract] [Full Text] [PDF]

Home page
 BloodHome page
A. Poggi, S. Negrini, M. R. Zocchi, A.-M. Massaro, L. Garbarino, S. Lastraioli, L. Gargiulo, L. Luzzatto, and R. Notaro
Patients with paroxysmal nocturnal hemoglobinuria have a high frequency of peripheral-blood T cells expressing activating isoforms of inhibiting superfamily receptors
Blood, October 1, 2005; 106(7): 2399 - 2408.
[Abstract] [Full Text] [PDF]

Home page
 Mayo Clin Proc.Home page
N. Gangat, Y. Lin, and P. L. Elkin
68-Year-Old Man With Fatigue, Fever, and Weight Loss
Mayo Clin. Proc., July 1, 2005; 80(7): 939 - 942.
[PDF]


HOME HELP CONTACT US SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
THE ONCOLOGIST STEM CELLS CME ALPHAMED PRESS JOURNALS


Copyright © 2004 by AlphaMed Press.
Advertisement